Kim Jaffe

Chief Business Officer at BlueSphere Bio

Kim Jaffe has held a variety of roles in the biopharmaceutical industry over the past 13 years. In 2021, they joined BlueSphere Bio as Senior Vice President, Head of Business Development & Strategy. Prior to that, they were Associate Vice President of Business Development & Operations at OncoSec from 2020-2021, Senior Director of Business Development and Project Management at OncoSec Immunotherapies from 2019-2020, Senior Director of Research and Director at Advaxis, Inc. from 2017-2019, and Principal Scientist at Oncobiologics Inc. from 2011-2017. From 2008-2011, they were a Postdoctoral Fellow at Princeton University, where they studied left-right patterning in early development using zebrafish as a model organism.

Kim Jaffe obtained a B.S. in Cell and Structural Biology with a minor in Chemistry from the University of Illinois Urbana-Champaign from 1998 to 2002. Subsequently, they attended Northwestern University from 2002 to 2007 and earned a Doctor of Philosophy (Ph.D.) in Biochemistry, Molecular and Cell Biology.

Location

New York, United States

Links


Org chart


Teams


Offices

This person is not in any offices


BlueSphere Bio

BlueSphere Bio is a novel TCXpress technology to unlock the potential of personalized T-cell therapy for the treatment of cancer .


Employees

11-50

Links